Neuroscience Market Research Report
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neuroscience Market
4. Market Overview
4.1. Introduction
4.1.1. End-user Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neuroscience Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Overview and Advancements: Brain Computer Interface
5.2. Research Trends of Mind Uploading
5.3. Technological Advancements
5.4. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid /long term impact)
6. Global Neuroscience Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Technology, 2017–2031
6.3.1. Whole Brain Imaging
6.3.2. Neuro-microscopy
6.3.3. Electrophysiology
6.3.4. Neuroproteomic Analysis
6.3.5. Animal Behavior Analysis
6.3.6. Neuro-functional Analysis
6.3.7. Others
6.4. Market Attractiveness Analysis, by Technology
7. Global Neuroscience Market Analysis and Forecast, by Component
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Component, 2017–2031
7.3.1. Instrument
7.3.2. Software
7.3.3. Services
7.4. Market Attractiveness Analysis, by Component
8. Global Neuroscience Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Academic & Research Institutions
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Neuroscience Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Neuroscience Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technology, 2017–2031
10.2.1. Whole Brain Imaging
10.2.2. Neuro-microscopy
10.2.3. Electrophysiology
10.2.4. Neuroproteomic Analysis
10.2.5. Animal Behavior Analysis
10.2.6. Neuro-functional Analysis
10.2.7. Others
10.3. Market Value Forecast, by Component, 2017–2031
10.3.1. Instrument
10.3.2. Software
10.3.3. Services
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Academic & Research Institutions
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By Component
10.6.3. By End-user
10.6.4. By Country
11. Europe Neuroscience Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2017–2031
11.2.1. Whole Brain Imaging
11.2.2. Neuro-microscopy
11.2.3. Electrophysiology
11.2.4. Neuroproteomic Analysis
11.2.5. Animal Behavior Analysis
11.2.6. Neuro-functional Analysis
11.2.7. Others
11.3. Market Value Forecast, by Component, 2017–2031
11.3.1. Instrument
11.3.2. Software
11.3.3. Services
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Academic & Research Institutions
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technology
11.6.2. By Component
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Neuroscience Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2017–2031
12.2.1. Whole Brain Imaging
12.2.2. Neuro-microscopy
12.2.3. Electrophysiology
12.2.4. Neuroproteomic Analysis
12.2.5. Animal Behavior Analysis
12.2.6. Neuro-functional Analysis
12.2.7. Others
12.3. Market Value Forecast, by Component, 2017–2031
12.3.1. Instrument
12.3.2. Software
12.3.3. Services
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Academic & Research Institutions
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Component
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Neuroscience Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2017–2031
13.2.1. Whole Brain Imaging
13.2.2. Neuro-microscopy
13.2.3. Electrophysiology
13.2.4. Neuroproteomic Analysis
13.2.5. Animal Behavior Analysis
13.2.6. Neuro-functional Analysis
13.2.7. Others
13.3. Market Value Forecast, by Component, 2017–2031
13.3.1. Instrument
13.3.2. Software
13.3.3. Services
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Academic & Research Institutions
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By Component
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Neuroscience Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technology, 2017–2031
14.2.1. Whole Brain Imaging
14.2.2. Neuro-microscopy
14.2.3. Electrophysiology
14.2.4. Neuroproteomic Analysis
14.2.5. Animal Behavior Analysis
14.2.6. Neuro-functional Analysis
14.2.7. Others
14.3. Market Value Forecast, by Component, 2017–2031
14.3.1. Instrument
14.3.2. Software
14.3.3. Services
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Academic & Research Institutions
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technology
14.6.2. By Component
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Rank Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. NEURALINK
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. Kernel
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis
15.3.3. BrainCo, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. MindMaze
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Paradromics
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. NeuroPro
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. NeuroSky
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. EMOTIV, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9. Cercare Medical A/S
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Growth Strategies
15.3.9.3. SWOT Analysis
15.3.10. Plexon, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Growth Strategies
15.3.10.3. SWOT Analysis
15.3.11. Noldus Information Technology B.V.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Growth Strategies
15.3.11.3. SWOT Analysis
15.3.12. Femtonics Ltd.
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Growth Strategies
15.3.12.3. SWOT Analysis
15.3.13. Neuralynx, Inc.
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Growth Strategies
15.3.13.3. SWOT Analysis
15.3.14. Neurable, Inc.
15.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.14.2. Growth Strategies
15.3.14.3. SWOT Analysis
15.3.15. Bitbrain Technologies
15.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.15.2. Growth Strategies
15.3.15.3. SWOT Analysis
15.3.16. Halo Neuroscience
15.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.16.2. Growth Strategies
15.3.16.3. SWOT Analysis
15.3.17. NeuroNexus Technologies, Inc.
15.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.17.2. Growth Strategies
15.3.17.3. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers